[MEDTalks Video] Does the Key Biomarker of Gaucher Disease Hold the Key to Understanding?
Illuminating Lyso-Gyl 1: Does the Key Biomarker of Gaucher Disease... Read more
Clinical Trials & Gaucher Disease: Phases, Types, & What You Should Know
Medical research has always been important for furthering our understanding... Read more
Repealing the Affordable Care Act
How Repealing the ACA Could Impact the Gaucher Disease... Read more
What You Should Know About At-Home Genetic and Ancestry Testing Kits
Genetic testing, including ancestry testing, has increased in popularity in... Read more
Gaucher Disease: Enzyme Replacement Therapy, Substrate Reduction Therapy & Potential Drug Interaction Side Effects
Substrate reduction therapy (SRT) first debuted as an alternative method... Read more
Ambassador Spotlight: Lauren Edwards
What were the events leading up to your diagnosis? What... Read more
Prevail Therapeutics Announces Investigational New Drug Trial for Parkinson’s Disease
U.S. Food and Drug Administration (FDA) has accepted Prevail’s Investigational... Read more
Tackling Mental Health Challenges Within the Gaucher Disease Community
Unlike other health problems, which may only affect one specific... Read more
Parkinson Disease Risk in the Gaucher Population
Leah Zaretsky, a Master’s Candidate in Genetic Counseling at Mt.... Read more
Ambassador Spotlight: Kelly Burns
What were the events leading up to your diagnosis? I... Read more
